Clinical trials: Seasickness
Motion Sickness, Seasickness
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study.
- Conditions
- Motion Sickness, Seasickness, Habituation, Vestibular Time Constant
- Trial name
- NCT05004818
- Testing
- GVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol
- Volunteers
- 54 people, healthy volunteers welcome
- Sponsor
- Medical Corps, Israel Defense Force
Motion Sickness, Space, Motion Sickness
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
The primary specific aim is to evaluate the use of intranasal scopolamine gel and sensory augmentation as an integrated countermeasure to mitigate motion sickness and enhance sensorimotor performance.
- Conditions
- Motion Sickness, Space, Motion Sickness, Sea Sickness
- Trial name
- NCT05886660
- Testing
- DPI-386 Nasal Gel
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Repurposed Therapeutics, Inc.
Sea Sickness
Video Head Impulse Test and Seasickness Susceptibility
This a case control study on seasickness susceptibility. 86 healthy maritime personal were divided to seasickness susceptible and non susceptible groups based on a seasickness questionnaire (Golding) and motion sickness score.
- Trial name
- NCT05657340
- Testing
- Video-head impulse testing
- Where
- Israel
- Volunteers
- 86 people, healthy volunteers welcome
- Sponsor
- Medical Corps, Israel Defense Force
Seasickness
Seasickness Susceptability and Vestibular Time Constant
Participants were selected from the military navy crewmembers prior to commencing of active sailing. A vestibular time constant was calculated based on velocity step testing on a rotatory chair at baseline, 3 months and 6 month…
- Trial name
- NCT05640258
- Testing
- rotatory chair testing in a velocity step protocol.
- Where
- Israel
- Volunteers
- 67 people, healthy volunteers welcome
- Sponsor
- Medical Corps, Israel Defense Force
Motion Sickness
Levo Phencynonate Hydrochloride for the Prevention of Seasickness
A double-blind, randomized, placebo controlled, multicenter, dose-finding phaseⅡclinical superiority study.
- Trial name
- NCT02241629
- Testing
- levo phencynonate hydrochloride
- Where
- China
- Volunteers
- 180 people, healthy volunteers welcome
- Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
Seasickness, Meclizine
Meclizine Plasma Levels in Responders and Non-responders
Motion sickness is a debilitating condition that can effect many crew members. Meclizine has long been known as an effective anti motion sickness drug.
- Trial name
- NCT04482985
- Testing
- Meclizine Hydrochloride
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Medical Corps, Israel Defense Force
Sea Sickness
Motion Sickness on Astrolabe's Vessel
Sea sickness syndrome is present for 80% of persons on board when the boat rotation missions Astrolabe, sometimes there is a risk of very significant dehydration.
- Trial name
- SICKVEST (NCT02911402)
- Testing
- sea sickness questionnaires
- Where
- France
- Volunteers
- 147 people, healthy volunteers welcome
- Sponsor
- University Hospital, Caen